Yuexiang Wang

机构：University of Science and Technology of China, Hefei Institutes of Physical Science, Shanghai Institute of Nutrition and Health · ORCID：0000-0003-3229-5467

发表论文 116 篇 · 总被引 4430 次 · h-index 33

代表论文

• Genomic and transcriptomic landscape of human gastrointestinal stromal tumors (2024 · Nature Communications · 被引 27)
• Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma (2024 · EMBO Molecular Medicine · 被引 24)
• Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway (2023 · Journal for ImmunoTherapy of Cancer · 被引 22)
• Self-assembled composite heterojunction material PDIsm/BiOCOOH promotes photocatalytic degradation of levofloxacin (2023 · Journal of Alloys and Compounds · 被引 21)
• Lipidomics and Transcriptomics Differ Liposarcoma Differentiation Characteristics That Can Be Altered by Pentose Phosphate Pathway Intervention (2022 · Metabolites · 被引 10)
• Activity of Anlotinib in the Second-Line Therapy of Metastatic Gastrointestinal Stromal Tumors: A Prospective, Multicenter, In Vitro Study (2023 · The Oncologist · 被引 9)